{
    "hands_on_practices": [
        {
            "introduction": "Effective surgical decision-making for sinonasal tumors often involves navigating diagnostic uncertainty. This practice problem simulates a common clinical dilemma: determining the necessity of dural resection when preoperative imaging is equivocal. By applying the principles of Bayesian inference and decision theory, you will learn to quantitatively weigh the risks of under-treatment against the harms of over-treatment, moving beyond simple heuristics to a rigorous, evidence-based choice.",
            "id": "5016116",
            "problem": "A $58$-year-old with an ethmoid-origin sinonasal adenocarcinoma is planned for anterior craniofacial resection. Preoperative Computed Tomography (CT) shows focal bony erosion of the cribriform plate. Magnetic Resonance Imaging (MRI) with contrast demonstrates no dural thickening or enhancement at the skull base. You are asked to justify whether dural resection should be included in the en bloc resection based on first principles of diagnostic test performance and decision theory.\n\nAssume the following scientifically plausible and literature-consistent parameters for detecting dural invasion by MRI: sensitivity $=0.70$, specificity $=0.95$. Based on the CT-demonstrated cribriform plate erosion in this clinical context, the pretest probability of microscopic dural invasion is estimated at $0.40$. For surgical decision-making, assign relative disutility (harm) values as follows: failing to resect dura when it is invaded (resulting in a positive margin and increased risk of intracranial recurrence) has a disutility of $10$ units; performing an unnecessary dural resection when dura is not invaded (resulting in additional morbidity such as Cerebrospinal Fluid (CSF) leak risk and longer reconstruction) has a disutility of $2$ units.\n\nUsing only the core definitions of sensitivity, specificity, and Bayesian conditional probability, and without invoking any shortcut formulas, determine the most defensible management choice regarding dural resection in the face of a negative MRI for dural enhancement. Which option is best justified?\n\nA. Proceed with dural resection, because with a negative MRI the posterior probability of dural invasion remains above the decision threshold implied by the relative harms.\n\nB. Defer dural resection, because a negative MRI lowers the post-test probability below the decision threshold implied by the relative harms.\n\nC. Avoid dural resection and plan adjuvant radiation only, because CT-detected cribriform plate erosion confers a low pretest probability that is further reduced by MRI.\n\nD. Obtain an intraoperative dural biopsy only (without resection), because the high MRI specificity means a negative MRI essentially rules out dural invasion.",
            "solution": "The problem statement is validated as follows.\n\n**Step 1: Extract Givens**\n- Patient: $58$-year-old with ethmoid-origin sinonasal adenocarcinoma.\n- Planned Surgery: Anterior craniofacial resection.\n- CT Finding: Focal bony erosion of the cribriform plate.\n- MRI Finding: Negative for dural thickening or enhancement (negative test result).\n- MRI Sensitivity for dural invasion: $S_e = 0.70$.\n- MRI Specificity for dural invasion: $S_p = 0.95$.\n- Pretest probability of dural invasion, given CT finding: $P(D) = 0.40$.\n- Disutility of failing to resect invaded dura (false negative decision outcome): $U(FN) = 10$ units.\n- Disutility of unnecessarily resecting uninvaded dura (false positive decision outcome): $U(FP) = 2$ units.\n- Task: Justify the management choice (dural resection or not) given a negative MRI, using core definitions of sensitivity, specificity, Bayesian probability, and decision theory.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding:** The problem is grounded in established principles of medical diagnostics (sensitivity, specificity), Bayesian statistics (updating probability based on new evidence), and decision theory (minimizing expected disutility). The clinical scenario and parameter values are plausible and consistent with medical literature. The problem is scientifically and mathematically sound.\n- **Well-Posedness:** All necessary quantities are provided to calculate a posterior probability and compare it against a decision threshold derived from the given disutilities. The problem is structured to yield a unique, quantitative answer.\n- **Objectivity:** The problem is stated in precise, objective terms.\n- **Completeness and Consistency:** The information is self-contained and free of contradictions.\n\n**Step 3: Verdict and Action**\n- The problem is valid. The solution process may proceed.\n\n**Derivation from First Principles**\n\nLet $D$ be the event that the patient has dural invasion, and $D^c$ be the event of no dural invasion. Let $MRI-$ denote a negative MRI result, and $MRI+$ a positive result. The provided parameters are:\n- Pretest probability of invasion: $P(D) = 0.40$.\n- The probability of no invasion is therefore: $P(D^c) = 1 - P(D) = 1 - 0.40 = 0.60$.\n- Sensitivity of MRI: $P(MRI+|D) = 0.70$.\n- Specificity of MRI: $P(MRI-|D^c) = 0.95$.\n\nThe patient has a negative MRI result. We must calculate the posterior (or post-test) probability of dural invasion given this new information, $P(D|MRI-)$. We use Bayes' theorem, which is defined as:\n$$P(D|MRI-) = \\frac{P(MRI-|D) \\cdot P(D)}{P(MRI-)}$$\n\nTo use this formula, we first need to find the terms in the numerator and the denominator.\n1.  The term $P(MRI-|D)$ is the probability of a negative MRI given that dural invasion is present. This is the false-negative rate of the test, which is the complement of the sensitivity:\n    $$P(MRI-|D) = 1 - P(MRI+|D) = 1 - 0.70 = 0.30$$\n2.  The term $P(MRI-)$ is the total probability of observing a negative MRI result. This can be calculated using the law of total probability, summing over the two possible states (dura invaded or not invaded):\n    $$P(MRI-) = P(MRI-|D) \\cdot P(D) + P(MRI-|D^c) \\cdot P(D^c)$$\n    We have all the necessary values:\n    - $P(MRI-|D) = 0.30$\n    - $P(D) = 0.40$\n    - $P(MRI-|D^c)$ is the specificity, given as $0.95$.\n    - $P(D^c) = 0.60$\n    Substituting these values:\n    $$P(MRI-) = (0.30)(0.40) + (0.95)(0.60) = 0.12 + 0.57 = 0.69$$\n\nNow we can calculate the posterior probability, $P(D|MRI-)$:\n$$P(D|MRI-) = \\frac{P(MRI-|D) \\cdot P(D)}{P(MRI-)} = \\frac{0.30 \\cdot 0.40}{0.69} = \\frac{0.12}{0.69} = \\frac{12}{69} = \\frac{4}{23}$$\nNumerically, this is $P(D|MRI-) \\approx 0.1739$. Let's call this posterior probability $P_{post}$.\n\nNext, we apply decision theory. The optimal decision is the one that minimizes the expected disutility. We must compare the expected disutility of resecting the dura versus not resecting it.\n\n-   **Expected disutility of resecting the dura, $E[U(\\text{Resect})]$**: If we resect, disutility is non-zero only if the dura is not invaded (an unnecessary resection, or false positive action). The disutility of this outcome is $U(FP) = 2$.\n    $$E[U(\\text{Resect})] = U(FP) \\cdot P(D^c|MRI-) = 2 \\cdot (1 - P_{post}) = 2 \\cdot (1 - 4/23) = 2 \\cdot (19/23) = 38/23 \\approx 1.652$$\n-   **Expected disutility of NOT resecting the dura, $E[U(\\text{No Resect})]$**: If we do not resect, disutility is non-zero only if the dura is invaded (a missed invasion, or false negative action). The disutility of this outcome is $U(FN) = 10$.\n    $$E[U(\\text{No Resect})] = U(FN) \\cdot P(D|MRI-) = 10 \\cdot P_{post} = 10 \\cdot (4/23) = 40/23 \\approx 1.739$$\n\nComparing the two expected disutilities, $E[U(\\text{Resect})] \\approx 1.652$ and $E[U(\\text{No Resect})] \\approx 1.739$. Since $1.652 < 1.739$, the action that minimizes expected disutility is to **resect the dura**.\n\nAlternatively, we can define a decision threshold probability, $P_{threshold}$. We should resect the dura if the expected disutility of not resecting exceeds that of resecting:\n$$E[U(\\text{No Resect})] > E[U(\\text{Resect})]$$\n$$U(FN) \\cdot P_{post} > U(FP) \\cdot (1 - P_{post})$$\n$$P_{post} \\cdot (U(FN) + U(FP)) > U(FP)$$\n$$P_{post} > \\frac{U(FP)}{U(FN) + U(FP)}$$\nThis inequality defines the threshold:\n$$P_{threshold} = \\frac{U(FP)}{U(FN) + U(FP)} = \\frac{2}{10 + 2} = \\frac{2}{12} = \\frac{1}{6}$$\nNumerically, $P_{threshold} \\approx 0.1667$.\n\nThe decision rule is: if the posterior probability of disease ($P_{post}$) is greater than the decision threshold ($P_{threshold}$), then treat (i.e., resect the dura).\n-   $P_{post} = 4/23 \\approx 0.1739$\n-   $P_{threshold} = 1/6 \\approx 0.1667$\nSince $0.1739 > 0.1667$ (or, comparing fractions, $4/23 > 1/6$ because $4 \\times 6 = 24$ is greater than $23 \\times 1 = 23$), the posterior probability is indeed above the decision threshold. Therefore, the most defensible action is to proceed with dural resection.\n\n**Option-by-Option Analysis**\n\n**A. Proceed with dural resection, because with a negative MRI the posterior probability of dural invasion remains above the decision threshold implied by the relative harms.**\nOur analysis shows the posterior probability of invasion, $P(D|MRI-)$, is approximately $0.174$. The decision threshold, derived from the given disutilities, is approximately $0.167$. Since $0.174 > 0.167$, the posterior probability is indeed above the threshold, and the correct action is to resect the dura. This statement is a perfect summary of our findings.\n**Verdict: Correct**\n\n**B. Defer dural resection, because a negative MRI lowers the post-test probability below the decision threshold implied by the relative harms.**\nThe negative MRI does lower the probability of invasion (from $0.40$ to $0.174$). However, this posterior probability ($0.174$) is not below the decision threshold ($0.167$). The premise leads to an incorrect conclusion.\n**Verdict: Incorrect**\n\n**C. Avoid dural resection and plan adjuvant radiation only, because CT-detected cribriform plate erosion confers a low pretest probability that is further reduced by MRI.**\nThe statement that a pretest probability of $0.40$ is \"low\" is a subjective judgment and highly questionable in a context where missing a diagnosis has severe consequences. More importantly, the decision does not depend on a qualitative assessment of probability but on a quantitative comparison to a threshold, which this option ignores. The conclusion to \"avoid dural resection\" is contrary to our analysis.\n**Verdict: Incorrect**\n\n**D. Obtain an intraoperative dural biopsy only (without resection), because the high MRI specificity means a negative MRI essentially rules out dural invasion.**\nThis reasoning is flawed. High specificity ($0.95$) means that a positive test is very likely to be a true positive. It does not imply that a negative test \"rules out\" the disease, especially with a significant pretest probability ($0.40$) and imperfect sensitivity ($0.70$). Our calculation shows a remaining risk of invasion of $17.4\\%$, which is far from \"ruled out\" and is substantial enough to warrant resection according to the decision framework.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Achieving histologically negative margins is a cornerstone of oncologic surgery, yet microscopic tumor extension is inherently invisible. This exercise challenges you to develop a quantitative model for surgical margin planning based on tumor biology. Using a hypothetical exponential distribution to represent microscopic spread, you will calculate the required margin width for different histologies, providing a clear illustration of how principles of probability can inform precise surgical execution.",
            "id": "5015981",
            "problem": "A surgeon is planning a craniofacial resection for anterior skull base (ASB) involvement by sinonasal malignancy. To ensure microscopically negative margins along a planned surgical plane, assume the one-dimensional microscopic extension distance beyond the visible tumor edge is a nonnegative random variable governed by an exponential distribution due to memoryless local infiltrative behavior. The mean microscopic extension distance differs by histology: for Squamous Cell Carcinoma (SCC), the mean is $3$ millimeters, and for Adenoid Cystic Carcinoma (ACC), the mean is $6$ millimeters, reflecting deeper perineural and submucosal spread in ACC. Let the exponential rate parameter be $\\lambda$ with mean $1/\\lambda$. The gross osteotomy introduces a fixed $1$ millimeter loss at the cut surface due to saw kerf, which must be added to the planned margin to preserve the intended microscopic clearance.\n\nDefine the required gross margin width $W$ as the minimal planned distance from the visible tumor edge to the cut such that the probability that the true microscopic extension is less than or equal to the net available margin (after accounting for kerf) is at least $0.95$. Using only the exponential model and the probability requirement, compute the required $W$ for SCC and ACC, respectively. Express the final margin widths in millimeters and round each to four significant figures.",
            "solution": "The problem requires the calculation of the minimal required gross surgical margin, $W$, for two different tumor histologies, Squamous Cell Carcinoma (SCC) and Adenoid Cystic Carcinoma (ACC), such that the probability of achieving complete microscopic resection is at least $0.95$. The model is based on an exponential distribution for microscopic tumor spread.\n\nFirst, we must formalize the provided information and define the mathematical framework. Let $X$ be the random variable representing the one-dimensional microscopic extension distance beyond the visible tumor edge. The problem states that $X$ follows an exponential distribution. The probability density function (PDF) of an exponential distribution with a rate parameter $\\lambda > 0$ is:\n$$f(x; \\lambda) = \\lambda \\exp(-\\lambda x), \\quad \\text{for } x \\ge 0$$\nThe corresponding cumulative distribution function (CDF), which gives the probability that the random variable $X$ is less than or equal to a specific value $x$, is:\n$$F(x; \\lambda) = P(X \\le x) = \\int_0^x \\lambda \\exp(-\\lambda t) \\,dt = 1 - \\exp(-\\lambda x), \\quad \\text{for } x \\ge 0$$\nThe mean of this distribution is related to the rate parameter by $E[X] = \\mu = \\frac{1}{\\lambda}$.\n\nThe problem provides the following parameters:\n- Mean microscopic extension for SCC: $\\mu_{SCC} = 3$ mm. The corresponding rate parameter is $\\lambda_{SCC} = \\frac{1}{\\mu_{SCC}} = \\frac{1}{3}$ mm$^{-1}$.\n- Mean microscopic extension for ACC: $\\mu_{ACC} = 6$ mm. The corresponding rate parameter is $\\lambda_{ACC} = \\frac{1}{\\mu_{ACC}} = \\frac{1}{6}$ mm$^{-1}$.\n- A fixed loss at the cut surface due to saw kerf: $k = 1$ mm.\n\nThe gross margin width, $W$, is the planned distance from the visible tumor edge to the location of the surgical cut. The saw kerf reduces this planned margin, resulting in a net available margin, $W_{net}$, which is what protects against the microscopic spread $X$. The net margin is:\n$$W_{net} = W - k$$\nThe condition for an adequate resection is that the probability of the microscopic extension $X$ being contained within this net available margin is at least $0.95$. This is expressed as:\n$$P(X \\le W_{net}) \\ge 0.95$$\nSubstituting the expression for $W_{net}$ and assuming a physically meaningful margin where $W > k$:\n$$P(X \\le W - k) \\ge 0.95$$\nUsing the CDF of the exponential distribution, this inequality becomes:\n$$1 - \\exp(-\\lambda (W - k)) \\ge 0.95$$\nTo determine the minimal required gross margin $W$, we solve the equation for the boundary condition:\n$$1 - \\exp(-\\lambda (W - k)) = 0.95$$\nWe now solve this equation for $W$. Rearranging the terms:\n$$\\exp(-\\lambda (W - k)) = 1 - 0.95$$\n$$\\exp(-\\lambda (W - k)) = 0.05$$\nTo isolate the exponent, we take the natural logarithm of both sides:\n$$-\\lambda (W - k) = \\ln(0.05)$$\nSolving for $(W - k)$:\n$$W - k = -\\frac{\\ln(0.05)}{\\lambda}$$\nSince $\\mu = \\frac{1}{\\lambda}$, we can substitute this into the equation:\n$$W - k = -\\mu \\ln(0.05)$$\nThe natural logarithm can be simplified: $\\ln(0.05) = \\ln(\\frac{5}{100}) = \\ln(\\frac{1}{20}) = -\\ln(20)$. Substituting this gives:\n$$W - k = -\\mu (-\\ln(20)) = \\mu \\ln(20)$$\nFinally, isolating $W$ yields the general formula for the required gross margin:\n$$W = k + \\mu \\ln(20)$$\nThis equation reveals that the required margin is the sum of the mechanical kerf and a biological safety margin that scales with the mean infiltration distance $\\mu$ and the desired confidence level (encoded in the $\\ln(20)$ term).\n\nWe can now compute the required margin for each histology.\n\nCase 1: Squamous Cell Carcinoma (SCC)\nUsing $\\mu_{SCC} = 3$ mm and $k = 1$ mm:\n$$W_{SCC} = 1 + 3 \\ln(20)$$\nTo obtain the numerical value, we use the approximation $\\ln(20) \\approx 2.99573227$:\n$$W_{SCC} \\approx 1 + 3(2.99573227) = 1 + 8.98719681 = 9.98719681$$\nThe problem requires rounding to four significant figures. Thus, the required margin for SCC is:\n$$W_{SCC} \\approx 9.987 \\text{ mm}$$\n\nCase 2: Adenoid Cystic Carcinoma (ACC)\nUsing $\\mu_{ACC} = 6$ mm and $k = 1$ mm:\n$$W_{ACC} = 1 + 6 \\ln(20)$$\nUsing the same approximation for $\\ln(20)$:\n$$W_{ACC} \\approx 1 + 6(2.99573227) = 1 + 17.97439362 = 18.97439362$$\nRounding to four significant figures, the required margin for ACC is:\n$$W_{ACC} \\approx 18.97 \\text{ mm}$$\nThe two computed values represent the minimal planned gross margins for SCC and ACC, respectively, under the given model and confidence requirement.",
            "answer": "$$\\boxed{\\begin{pmatrix} 9.987 & 18.97 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Multimodality treatment, including surgery and radiation, is standard for advanced sinonasal cancers, but it carries the risk of cumulative toxicity to normal tissues. This problem focuses on the critical task of tracking radiation dose to the optic chiasm across two separate treatment courses using the linear-quadratic model. Mastering these calculations is essential for participating in multidisciplinary treatment planning and ensuring patient safety by respecting the tolerance of critical structures like the optic pathways.",
            "id": "5016000",
            "problem": "A patient with an anterior skull base sinonasal adenocarcinoma underwent craniofacial resection followed by adjuvant Intensity-Modulated Radiation Therapy (IMRT) and, after a local recurrence, stereotactic salvage with Stereotactic Body Radiotherapy (SBRT). The optic chiasm lies within the high-gradient region of both plans. The clinical objective is to determine the composite dose to the hottest point within the optic chiasm from the overlapping fields and verify whether the cumulative exposure remains below the established tolerance of $54$ Gy in $2$ Gy fraction-equivalent terms for late optic pathway toxicity.\n\nPlan parameters:\n- Adjuvant IMRT: $30$ fractions, prescription dose per fraction to the planning target volume is $2$ Gy. From the dose–volume histogram (DVH), the maximum point dose within the optic chiasm per fraction is $1.5$ Gy.\n- Salvage SBRT: $5$ fractions, prescription dose per fraction to the gross recurrence is $5$ Gy. From the DVH, the maximum point dose within the optic chiasm per fraction is $2.0$ Gy.\n- For late-responding neural tissue (optic chiasm), take $\\alpha/\\beta = 2$ Gy.\n\nAssume the same hottest voxel receives the stated maximum point dose in each fraction of both courses (a worst-case summation), and assume temporal repair characteristics are adequately captured by the linear–quadratic model for fractionation effects. Using radiobiological equivalence based on the linear–quadratic model and summation appropriate for sequential exposures, compute the composite equivalent dose in $2$ Gy fractions received by the hottest point in the optic chiasm. Round your final composite equivalent dose to three significant figures and express your answer in Gy. Then, using this computed value, verify in your reasoning if it remains below the threshold of $54$ Gy in $2$ Gy fraction-equivalent terms.",
            "solution": "The problem requires the calculation of the composite cumulative dose to the optic chiasm from two sequential courses of radiation therapy, expressed in terms of equivalent dose in $2$ Gy fractions ($EQD_2$). The calculation will be based on the linear-quadratic (LQ) model, which is the standard for quantifying the biological effects of different fractionation schedules in radiation therapy.\n\nFirst, we validate the problem. All provided parameters are scientifically plausible and consistent with clinical practice in radiation oncology. The values for dose per fraction, number of fractions for both adjuvant and salvage treatments, and the $\\alpha/\\beta$ ratio for late-reacting neural tissue are standard. The problem is well-posed, objective, and scientifically grounded. Therefore, we proceed with the solution.\n\nThe fundamental quantity used for comparing different fractionation schemes is the Biological Effective Dose (BED), given by the formula:\n$$ \\text{BED} = N \\cdot d \\left(1 + \\frac{d}{\\alpha/\\beta}\\right) $$\nwhere $N$ is the number of fractions, $d$ is the dose per fraction to the tissue of interest, and $\\alpha/\\beta$ is the tissue-specific parameter.\n\nWe are given the following parameters for the optic chiasm:\n-   Alpha/beta ratio, $\\alpha/\\beta = 2$ Gy.\n\nFor the first treatment course (adjuvant IMRT):\n-   Number of fractions, $N_1 = 30$.\n-   Maximum point dose to the optic chiasm per fraction, $d_1 = 1.5$ Gy.\n\nWe calculate the BED for the first course, $\\text{BED}_1$:\n$$ \\text{BED}_1 = N_1 d_1 \\left(1 + \\frac{d_1}{\\alpha/\\beta}\\right) $$\nSubstituting the values:\n$$ \\text{BED}_1 = 30 \\cdot (1.5) \\left(1 + \\frac{1.5}{2}\\right) $$\n$$ \\text{BED}_1 = 45 \\left(1 + 0.75\\right) $$\n$$ \\text{BED}_1 = 45 \\cdot (1.75) $$\n$$ \\text{BED}_1 = 78.75 \\, \\text{Gy} $$\n\nFor the second treatment course (salvage SBRT):\n-   Number of fractions, $N_2 = 5$.\n-   Maximum point dose to the optic chiasm per fraction, $d_2 = 2.0$ Gy.\n\nWe calculate the BED for the second course, $\\text{BED}_2$:\n$$ \\text{BED}_2 = N_2 d_2 \\left(1 + \\frac{d_2}{\\alpha/\\beta}\\right) $$\nSubstituting the values:\n$$ \\text{BED}_2 = 5 \\cdot (2.0) \\left(1 + \\frac{2.0}{2}\\right) $$\n$$ \\text{BED}_2 = 10 \\left(1 + 1\\right) $$\n$$ \\text{BED}_2 = 10 \\cdot (2) $$\n$$ \\text{BED}_2 = 20 \\, \\text{Gy} $$\n\nThe problem assumes a worst-case scenario where the biological effects of the two sequential treatments are additive. Therefore, the composite BED, $\\text{BED}_{\\text{comp}}$, is the sum of the individual BEDs:\n$$ \\text{BED}_{\\text{comp}} = \\text{BED}_1 + \\text{BED}_2 $$\n$$ \\text{BED}_{\\text{comp}} = 78.75 + 20 = 98.75 \\, \\text{Gy} $$\n\nThe final step is to convert this composite BED into an equivalent dose in $2$ Gy fractions, denoted as $EQD_2$. The $EQD_2$ is the total physical dose that would produce the same biological effect if delivered in fractions of $2$ Gy. The relationship is given by:\n$$ \\text{BED} = (\\text{EQD}_2) \\left(1 + \\frac{d_{\\text{ref}}}{\\alpha/\\beta}\\right) $$\nwhere $d_{\\text{ref}} = 2$ Gy. Rearranging for $EQD_2$:\n$$ \\text{EQD}_2 = \\frac{\\text{BED}}{1 + \\frac{d_{\\text{ref}}}{\\alpha/\\beta}} $$\nUsing our composite BED and the given parameters:\n$$ EQD_{2, \\text{comp}} = \\frac{\\text{BED}_{\\text{comp}}}{1 + \\frac{2}{2}} = \\frac{98.75}{1+1} = \\frac{98.75}{2} $$\n$$ EQD_{2, \\text{comp}} = 49.375 \\, \\text{Gy} $$\n\nThe problem requests the final answer to be rounded to three significant figures.\n$$ EQD_{2, \\text{comp}} \\approx 49.4 \\, \\text{Gy} $$\n\nFinally, we must verify if this composite dose is below the established tolerance limit of $54$ Gy for the optic chiasm.\nThe calculated composite dose is $49.4$ Gy. The tolerance limit is $54$ Gy.\nSince $49.4$ Gy $< 54.0$ Gy, the composite dose to the hottest point in the optic chiasm, under the assumptions of the linear-quadratic model and worst-case spatial summation, is below the tolerance threshold for late optic pathway toxicity.",
            "answer": "$$\n\\boxed{49.4}\n$$"
        }
    ]
}